Aceclofenac Tablets IP 100 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Aceclofenac Tablets IP 100 mg | Manufacturer
Product image for Aceclofenac Tablets IP 100 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Aceclofenac |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Analgesic and Anti-inflammatory Drugs |
| Subcategory | Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) |
| Active Ingredient | Aceclofenac |
| Strength | 100 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Musculo-Skeletal System - Anti-inflammatory and Antirheumatic Products |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Aceclofenac Tablets IP 100 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Symptomatic relief of pain, morning stiffness, and inflammation in Osteoarthritis. 2. Chronic joint pain and functional mobility improvement in Rheumatoid Arthritis. 3. Management of spinal stiffness and inflammation in Ankylosing Spondylitis. 4. Acute painful musculoskeletal conditions, lumbago, dentalgia, post-surgical trauma, and primary dysmenorrhea. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Aceclofenac Tablets IP 100 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Aceclofenac Tablets IP 100 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production. Quality control and assuranceRequest the approved finished-product specification for Aceclofenac Tablets IP 100 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability. Primary and secondary packagingThe catalogue pack for Aceclofenac Tablets IP 100 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification. Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Adult Dosage: Standard therapeutic dose is 100 mg twice daily (one tablet morning and evening), swallowed whole with water, preferably with or immediately following meals to minimize gastrointestinal discomfort. Elderly: No routine dosage alteration required. Hepatic Impairment: In patients with mild-to-moderate hepatic dysfunction, reduce the starting dose to 100 mg once daily. | ||||||||||||||||||||||||
| Side Effects | Common (1-10%): Dyspepsia, epigastric discomfort, nausea, diarrhea, abdominal pain, elevated hepatic enzymes. Uncommon (0.1-1%): Flatulence, gastritis, constipation, dizziness, pruritus, skin rash, urticaria. Rare to Very Rare (<0.1%): Peptic ulceration, gastrointestinal hemorrhage, melena, toxic epidermal necrolysis, Stevens-Johnson syndrome, nephrotoxicity. | ||||||||||||||||||||||||
| Warnings and Precautions | Cardiovascular Risk: NSAIDs may increase the risk of serious arterial thrombotic events, myocardial infarction, and stroke; use the lowest effective dose for the shortest duration. Gastrointestinal Risk: Potential for serious gastrointestinal ulceration, perforation, and bleeding without warning symptoms. Renal & Hepatic Monitoring: Regular assessment of renal parameters (BUN/creatinine) and transaminases is recommended in patients with compromised organ function or elderly individuals. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to aceclofenac, diclofenac, or aspirin-induced asthma, urticaria, or acute rhinitis. 2. Active, recurrent peptic ulcer or active gastrointestinal bleeding/perforation. 3. Established congestive heart failure (NYHA class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease. 4. Severe hepatic failure or advanced renal impairment (CrCl < 30 mL/min). 5. Third trimester of pregnancy. | ||||||||||||||||||||||||
| Drug Interactions | 1. Anticoagulants (Warfarin, Heparin) & Antiplatelets: Markedly elevated risk of serious gastrointestinal hemorrhage. 2. Antihypertensives & Diuretics: Attenuation of antihypertensive effect and increased risk of acute renal failure. 3. Methotrexate & Lithium: Reduced renal clearance resulting in toxic plasma elevations of methotrexate and lithium. 4. Corticosteroids: Increased ulcerogenic potential and gastrointestinal bleeding risk. 5. Cyclosporine & Tacrolimus: Enhanced nephrotoxicity mediated by renal prostaglandin inhibition. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Aceclofenac Tablets IP 100 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Aceclofenac Tablets IP 100 mg? | The source specification is IP; confirm the required standard before contracting. |
| What quality tests are applicable for Aceclofenac Tablets IP 100 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Aceclofenac Tablets IP 100 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Aceclofenac Tablets IP 100 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products












